Shareholder Yield % is how much money shareholders receive from a company that is in the form of cash dividends, net stock repurchases, and debt reduction. It is a measure of shareholder return.
As of today, Greenway Greenhouse Cannabis's Shareholder Yield % was 1.13%.
Shareholder Yield % is how much money shareholders receive from a company that is in the form of cash dividends, net stock repurchases, and debt reduction. The term was coined by William W. Priest of Epoch Investment Partners in a paper in 2005 entitled The Case for Shareholder Yield as a Dominant Driver of Future Equity Returns. William Priest indicated that "shareholder yield is a term that we came up with to reflect the various ways dividends can be paid to owners of a business in a publicly-traded company."
Dividend Yield % shows how much a company pays out in dividends each year relative to its stock price, which is most obvious form of shareholder return.
Buyback Yield % is the net repurchase of shares outstanding over the market capital of the company. Shares repurchases also increase shareholder value by returning the money back to shareholders.
Net Debt Paydown Yield % is the change in average of four quarters of company's total debt over a company's market cap. Assuming the total value of a company remains that same, shareholder value is increased as debt is reduced.
Greenway Greenhouse Cannabis Shareholder Yield % Related Terms
Greenway Greenhouse Cannabis Shareholder Yield % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
GWAYF vs ZTS, UTHR: Shareholder Yield % Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Greenway Greenhouse Cannabis's Shareholder Yield %, along with its competitors' market caps and Shareholder Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Greenway Greenhouse Cannabis Shareholder Yield % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Greenway Greenhouse Cannabis's Shareholder Yield % distribution charts can be found below:
* The bar in red indicates where Greenway Greenhouse Cannabis's Shareholder Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* All the data are calculated by TTM values. Note that if a companies is traded in several exchanges, then we calculate the company level data for Shareholder Yield % using the primary share class stock data. The calculation result in definition page is for demonstration purpose only, and it's showing the share class level data. Therefore, the numbers in the calculation may differ from elsewhere if the stock is not a primary share.
Greenway Greenhouse Cannabis (GWAYF) has a Shareholder Yield % of 1.13% as of Dec. 2025. Shareholder Yield is how much money shareholders receive from a company that is in the form of cash dividends, net stock repurchases, and debt reduction. View historical data on Greenway Greenhouse Cannabis and its competitors. According to the industry distribution chart, Greenway Greenhouse Cannabis ranks #416 out of 969 companies in the Drug Manufacturers industry, placing it in the top 42.9%.
Is Greenway Greenhouse Cannabis' Shareholder Yield % too high?
Greenway Greenhouse Cannabis' current Shareholder Yield % is 1.13%. The Drug Manufacturers industry median Shareholder Yield % is 0.34. Greenway Greenhouse Cannabis' value of 1.13% is 232.4% above this industry median. Based on the distribution chart, Greenway Greenhouse Cannabis ranks #416 out of 969 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, Greenway Greenhouse Cannabis has a GF Score™ of 24/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Greenway Greenhouse Cannabis' Shareholder Yield % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Greenway Greenhouse Cannabis ranks #416 out of 969 companies for Shareholder Yield %. This puts Greenway Greenhouse Cannabis in the upper half of its industry. The industry median Shareholder Yield % is 0.34. Greenway Greenhouse Cannabis' value of 1.13% is 232.4% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Shareholder Yield % for a Drug Manufacturers company?
The median Shareholder Yield % among Drug Manufacturers companies is 0.34, based on 969 companies in the industry. Companies in the top quartile (top 25%) have a Shareholder Yield % significantly above this median, while those in the bottom quartile fall well below. However, Shareholder Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Greenway Greenhouse Cannabis's current Shareholder Yield % of 1.13% is 232.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Shareholder Yield % mean?
A high Shareholder Yield % can signal that a stock is expensive relative to its fundamentals. Shareholder Yield is how much money shareholders receive from a company that is in the form of cash dividends, net stock repurchases, and debt reduction. View historical data on Greenway Greenhouse Cannabis and its competitors. For the Drug Manufacturers industry, the median Shareholder Yield % is 0.34 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Greenway Greenhouse Cannabis's current Shareholder Yield % is 1.13%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Greenway Greenhouse Cannabis stock overvalued right now?
Based on GuruFocus' analysis, Greenway Greenhouse Cannabis (GWAYF) is currently considered Possible Value Trap. The stock's GF Value™ is $0.29, compared to a current price of $0.10 — trading 64.8% below its estimated fair value. The current Shareholder Yield % is 1.13% and 232.4% above the Drug Manufacturers industry median of 0.34. Greenway Greenhouse Cannabis' overall GF Score™ is 24/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Shareholder Yield % calculated?
Shareholder Yield % is calculated from a company's financial statements. For Greenway Greenhouse Cannabis (GWAYF), the current Shareholder Yield % is 1.13% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Greenway Greenhouse Cannabis (GWAYF) Overvalued in 2026?
Based on GuruFocus' analysis, Greenway Greenhouse Cannabis stock appears to be undervalued.
The current stock price of $0.10 is trading 64.8% below its estimated GF Value™ of $0.29.
GuruFocus considers Greenway Greenhouse Cannabis to be Possible Value Trap.
Key valuation signals for GWAYF:
Shareholder Yield %: 1.13%
GF Value™: $0.29 vs. price of $0.10 (64.8% below fair value)
Industry Position: 232.4% above the Drug Manufacturers median (#416 of 969)
No single metric tells the full story. See the GWAYF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Greenway Greenhouse Cannabis Corp is licensed to cultivate, process and sell to ensures harvests always consist of the highest quality cannabis strains with resinous flowers, trichomes, and rich cannabinoid profiles. The Company's nursery facility is located in Kingsville, Ontario, and its flowering and processing facility is located in Leamington, Ontario. The business model is to supply bulk packaged, high quality cannabis to the Canadian, cannabis industry at prices that ultimately provide a value proposition to the consumers. Greenway has three divisions with various locations; Greenway Nursery, Greenway Cultivation and future plans for Greenway Farmgate Retail Store.
24GF Score
Get the complete analysis for GWAYF
Shareholder Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
GWAYF has been successfully added to your 
